| __timestamp | Catalent, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 334800000 | 2999000 |
| Thursday, January 1, 2015 | 337300000 | 10393000 |
| Friday, January 1, 2016 | 358100000 | 15994000 |
| Sunday, January 1, 2017 | 402600000 | 26975000 |
| Monday, January 1, 2018 | 462600000 | 39509000 |
| Tuesday, January 1, 2019 | 512000000 | 48869000 |
| Wednesday, January 1, 2020 | 577900000 | 42510000 |
| Friday, January 1, 2021 | 687000000 | 46105000 |
| Saturday, January 1, 2022 | 844000000 | 50513000 |
| Sunday, January 1, 2023 | 831000000 | 51292000 |
| Monday, January 1, 2024 | 935000000 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical industry, understanding the financial dynamics of key players is crucial. Catalent, Inc. and Wave Life Sciences Ltd. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Catalent's SG&A expenses surged by approximately 179%, reflecting its aggressive expansion and strategic investments. In contrast, Wave Life Sciences Ltd. experienced a more modest increase of around 1,610%, albeit from a much smaller base, indicating its growth phase and scaling efforts.
Catalent's expenses peaked in 2024, while Wave Life Sciences Ltd. data for the same year remains unavailable, highlighting potential reporting gaps. These trends underscore the differing strategies and market positions of these companies, offering valuable insights for investors and industry analysts alike.
Who Optimizes SG&A Costs Better? Sanofi or Catalent, Inc.
Selling, General, and Administrative Costs: Biogen Inc. vs Wave Life Sciences Ltd.
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Catalent, Inc.
Cost Management Insights: SG&A Expenses for Catalent, Inc. and CymaBay Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and CRISPR Therapeutics AG
Cost Management Insights: SG&A Expenses for Catalent, Inc. and Taro Pharmaceutical Industries Ltd.
SG&A Efficiency Analysis: Comparing Catalent, Inc. and Evotec SE
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Wave Life Sciences Ltd. Trends and Insights
SG&A Efficiency Analysis: Comparing Viking Therapeutics, Inc. and Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Amicus Therapeutics, Inc. or Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared